SureshKumarBalasubramanianMD
Hematology • Detroit, MIHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor/ Department of Oncology
Dr. Balasubramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4100 John R
Detroit, MI 48202Phone+1 313-576-8740
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2017 - 2020
Cleveland ClinicPost-Doctoral Fellowship, 2016 - 2017
St Vincent Charity Medical CenterResidency, Internal Medicine, 2012 - 2015
Madras Medical CollegeClass of 2007, MBBS
Certifications & Licensure
MI State Medical License 2017 - 2027
OH State Medical License 2012 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Targeting Menin in Acute Myeloid Leukemia: Therapeutic Advances and Future Directions.Sandhya Dhiman, Vikram Dhillon, Suresh Kumar Balasubramanian
Cancers. 2024-11-06 - 1 citationsClinical and molecular characteristics of extramedullary acute myeloid leukemias.Tariq Kewan, Waled S Bahaj, Carmelo Gurnari, Olisaemeka D Ogbue, Sudipto Mukherjee
Leukemia. 2024-09-01 - 1 citationsParoxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysis.Carmelo Gurnari, Hussein Awada, Simona Pagliuca, Danai Dima, Fauzia Ullah
Blood. 2024-07-11
Abstracts/Posters
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab OzogamicinSuresh Kumar Balasubramanian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with BlinatumomabSuresh Kumar Balasubramanian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Brain Metastases Do Not Influence Outcome in Patients with Mutated NSCLCJune 6th, 2016
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Telugu, Hindi, Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
